Neuromuscular degeneration

Doctors need to understand absolute versus relative risk reduction with statins

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8357 (Published 10 December 2012)
Cite this as: BMJ 2012;345:e8357

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Bernard Freudenthal, core medical trainee year 11
  1. 1Chase Farm Hospital, Enfield EN2 8JL, UK
  1. b.freudenthal{at}doctors.org.uk

In this Patient’s Journey, Mustafa Gunaydin presented to various doctors with marked subjective intolerance of statins before later developing myositis.1 It seems extraordinary that his doctors were so committed to continued …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL